[Botulinum toxin therapy for spasmodic torticollis: medical and non-medical adjunct treatment]
- PMID: 23371379
- DOI: 10.1007/s00115-012-3708-1
[Botulinum toxin therapy for spasmodic torticollis: medical and non-medical adjunct treatment]
Abstract
Background: Spasmodic torticollis patients were investigated with respect to the number of adjunct treatments used before and after the introduction of botulinum toxin therapy (Btx). The study was designed in a similar way to an earlier investigation by Birner et al. (Nervenarzt 70:903-908, 1999).
Material and methods: A total of 247 patients with idiopathic spasmodic torticollis were assessed at three time points for the diagnosis: before 1988 (n = 63), between 1989 and 1998 (n = 107) and after 1999 (n = 77).
Results: Independent of the year of diagnosis patients underwent a mean of 14.3 different treatments. In addition to Btx most of the patients were subjected to massage, physiotherapy, medication and a large number of non-medical treatments including praying. No associations to clinical or personal variables were found. Those patients with emotional disorders prior to onset of dystonia displayed a higher rate of medical and non-medical treatments in addition to Btx.
Conclusions: The results confirmed those found by Birner et al.. In order to enhance compliance patients should undergo psychoeducation with respect to illness behaviour and specific history taking with respect to emotional disorders prior to dystonia.
Similar articles
-
Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.J Neuropsychiatry Clin Neurosci. 1994 Winter;6(1):50-3. doi: 10.1176/jnp.6.1.50. J Neuropsychiatry Clin Neurosci. 1994. PMID: 8148637
-
Outcome of selective ramisectomy for botulinum toxin resistant torticollis.J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):472-8. doi: 10.1136/jnnp.65.4.472. J Neurol Neurosurg Psychiatry. 1998. PMID: 9771768 Free PMC article.
-
BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).Mov Disord. 1997 Sep;12(5):772-5. doi: 10.1002/mds.870120526. Mov Disord. 1997. PMID: 9380065
-
Spasmodic torticollis: medical and botulinum A toxin treatment.Yonsei Med J. 1992 Dec;33(4):289-93. doi: 10.3349/ymj.1992.33.4.289. Yonsei Med J. 1992. PMID: 1364066 Review.
-
Botulinum toxin therapy for cervical dystonia.Phys Med Rehabil Clin N Am. 2003 Nov;14(4):749-66, vi. doi: 10.1016/s1047-9651(03)00045-7. Phys Med Rehabil Clin N Am. 2003. PMID: 14580035 Review.
Cited by
-
Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy.Front Neurol. 2020 Nov 12;11:588395. doi: 10.3389/fneur.2020.588395. eCollection 2020. Front Neurol. 2020. PMID: 33281726 Free PMC article.
-
Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia.Patient Prefer Adherence. 2017 Sep 14;11:1555-1563. doi: 10.2147/PPA.S141060. eCollection 2017. Patient Prefer Adherence. 2017. PMID: 29066869 Free PMC article.
-
The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.Toxins (Basel). 2021 Jul 16;13(7):493. doi: 10.3390/toxins13070493. Toxins (Basel). 2021. PMID: 34357965 Free PMC article.
-
The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation-A Monocentric Cross-Sectional Pilot Study.Medicina (Kaunas). 2022 Jan 7;58(1):88. doi: 10.3390/medicina58010088. Medicina (Kaunas). 2022. PMID: 35056396 Free PMC article.
-
Individual Response to Botulinum Toxin Therapy in Movement Disorders: A Time Series Analysis Approach.Toxins (Basel). 2022 Jul 24;14(8):508. doi: 10.3390/toxins14080508. Toxins (Basel). 2022. PMID: 35893750 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical